Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 3Phase 3 2Phase 2/3 2Phase 1/2 2

Status

Completed 3Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 1Advanced and/or Metastatic Solid Tumours 1Advanced Esophageal 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × nimotuzumab × Clear all
NCT02947386 2023-10-05

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 1 Completed
7 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00950417 2015-08-19

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 1 Completed
11 enrolled
Gastrointestinal

Advanced Esophageal

NCT00369252 2007-02-28

Phase I Study of Nimotuzumab in Solid Tumours

YM BioSciences

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡